Scholars@Duke publication: Pharmacokinetics of rifampicin.

Pharmacokinetics of rifampicin.

Publication , Journal Article

Beth Gadkowski, L; Stout, JE

Published in: Clin Infect Dis

February 15, 2007

Published version (DOI) Link to item

Duke Scholars

Author Jason Eric Stout Medicine, Infectious Diseases

Published In

Clin Infect Dis

DOI

10.1086/511081

EISSN

1537-6591

Publication Date

February 15, 2007

Volume

Issue

Start / End Page

618 / 619

Location

United States

Related Subject Headings

Tuberculosis
Treatment Outcome
Sensitivity and Specificity
Risk Factors
Rifampin
Microbiology
Male
Humans
Female
Drug Administration Schedule

Citation

APA

Chicago

ICMJE

MLA

NLM

Beth Gadkowski, L., & Stout, J. E. (2007). Pharmacokinetics of rifampicin. Clin Infect Dis, 44(4), 618–619. https://doi.org/10.1086/511081

Beth Gadkowski, L., and Jason E. Stout. “Pharmacokinetics of rifampicin.” Clin Infect Dis 44, no. 4 (February 15, 2007): 618–19. https://doi.org/10.1086/511081.

Beth Gadkowski L, Stout JE. Pharmacokinetics of rifampicin. Clin Infect Dis. 2007 Feb 15;44(4):618–9.

Beth Gadkowski, L., and Jason E. Stout. “Pharmacokinetics of rifampicin.” Clin Infect Dis, vol. 44, no. 4, Feb. 2007, pp. 618–19. Pubmed, doi:10.1086/511081.

Beth Gadkowski L, Stout JE. Pharmacokinetics of rifampicin. Clin Infect Dis. 2007 Feb 15;44(4):618–619.

Published In

Clin Infect Dis

DOI

10.1086/511081

EISSN

1537-6591

Publication Date

February 15, 2007

Volume

Issue

Start / End Page

618 / 619

Location

United States

Related Subject Headings

Tuberculosis
Treatment Outcome
Sensitivity and Specificity
Risk Factors
Rifampin
Microbiology
Male
Humans
Female
Drug Administration Schedule